Tapewire

Nasdaq · USD

AUPH

Aurinia Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
4463
SEC CIK
0001600620
Parsed reports
183

Last 12 months

Inside the activity.

11 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202630
Mar 202630
Apr 202600
May 202620
Jun 202630
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2026 Filed Jan 5, 2026 21:12 UTC
Donley Matthew MaxwellChief Operating Officer
GrantCommon Stock 54,166 $0.00 $0.00
Disclosure

SEC source: 0001600620-26-000004 · wk-form4_1767647524.xml · nonDerivative · entry 1

Donley Matthew Maxwell · CIK 0001636642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 734,631

F1 · shares: Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026.

Read SEC document
November 21, 2025 Filed Nov 24, 2025 22:19 UTC Tax withholdingCommon Shares 2,716 $15.68 $42,586.88
Disclosure

SEC source: 0001600620-25-000110 · wk-form4_1764022752.xml · nonDerivative · entry 1

Bailey Jeffrey Allen · CIK 0001500210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,775

F1 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.

Read SEC document
November 21, 2025 Filed Nov 24, 2025 22:17 UTC Tax withholdingCommon Shares 6,039 $15.68 $94,691.52
Disclosure

SEC source: 0001370348-25-000004 · wk-form4_1764022670.xml · nonDerivative · entry 1

Johnson Craig A · CIK 0001370348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,592

F1 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.

Read SEC document
August 05, 2025 Filed Aug 5, 2025 21:31 UTC
TANG KEVINDirector
PurchaseCommon Shares 200,000 $11.68 $2,336,000.00
Disclosure

SEC source: 0001415889-25-021066 · form4-08052025_090800.xml · nonDerivative · entry 3

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 11,329,500

F4 · price: These shares were purchased in multiple transactions ranging from $11.49 to $11.80.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 6,371,711 shares and Tang Capital Partners International, LP ("TCPI") beneficially owns 4,957,789 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCPI.

Read SEC document
August 04, 2025 Filed Aug 5, 2025 21:31 UTC
TANG KEVINDirector
PurchaseCommon Shares 100,000 $11.34 $1,134,000.00
Disclosure

SEC source: 0001415889-25-021066 · form4-08052025_090800.xml · nonDerivative · entry 2

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 11,129,500

F3 · price: These shares were purchased in multiple transactions ranging from $11.11 to $11.48.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 6,371,711 shares and Tang Capital Partners International, LP ("TCPI") beneficially owns 4,957,789 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCPI.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 21:31 UTC
TANG KEVINDirector
PurchaseCommon Shares 1,000,000 $10.12 $10,120,000.00
Disclosure

SEC source: 0001415889-25-021066 · form4-08052025_090800.xml · nonDerivative · entry 1

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 11,029,500

F1 · price: The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $9.23 to $10.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1, 3 and 4.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 6,371,711 shares and Tang Capital Partners International, LP ("TCPI") beneficially owns 4,957,789 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCPI.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:07 UTC
Keenan GregChief Medical Officer
SaleCommon Stock 20,000 $10.50 $210,000.00
Disclosure

SEC source: 0001600620-25-000095 · wk-form4_1754424444.xml · nonDerivative · entry 1

Keenan Greg · CIK 0002044006 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,484

F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $10.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 16, 2025 Filed May 16, 2025 21:04 UTC GrantDirector Stock Option (right to buy) · Derivative 63,724 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0001600620-25-000076 · wk-form4_1747429477.xml · derivative · entry 1

Goetz Kathleen · CIK 0001896369 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,724

Underlying: Common Shares · 63,724 shares

Expires 2035-05-16

F1 · derivative.exercise_date: The options shall vest one year from date of grant.

Read SEC document
May 16, 2025 Filed May 16, 2025 21:04 UTC GrantDirector Stock Option (right to buy) · Derivative 37,485 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0001600620-25-000075 · wk-form4_1747429452.xml · derivative · entry 1

Bailey Jeffrey Allen · CIK 0001500210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,485

Underlying: Common Shares · 37,485 shares

Expires 2035-05-16

F1 · derivative.exercise_date: The options shall vest one year from date of grant.

Read SEC document
May 16, 2025 Filed May 16, 2025 21:06 UTC GrantDirector Stock Option (right to buy) · Derivative 63,724 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0001600620-25-000078 · wk-form4_1747429558.xml · derivative · entry 1

Nova Tina Susan · CIK 0001302605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,724

Underlying: Common Shares · 63,724 shares

Expires 2035-05-16

F1 · derivative.exercise_date: The options shall vest one year from date of grant.

Read SEC document
May 16, 2025 Filed May 16, 2025 21:05 UTC GrantDirector Stock Option (right to buy) · Derivative 37,485 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0001600620-25-000077 · wk-form4_1747429513.xml · derivative · entry 1

Johnson Craig A · CIK 0001370348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,485

Underlying: Common Shares · 37,485 shares

Expires 2035-05-16

F1 · derivative.exercise_date: The options shall vest one year from date of grant.

Read SEC document
March 07, 2025 Filed Mar 7, 2025 22:25 UTC
Keenan GregChief Medical Officer
SaleCommon Stock 8,305 $8.23 $68,350.15
Disclosure

SEC source: 0001600620-25-000026 · wk-form4_1741386297.xml · nonDerivative · entry 1

Keenan Greg · CIK 0002044006 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,484

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 6, 2023 grant.

F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 04, 2025 Filed Mar 4, 2025 22:03 UTC
TANG KEVINDirector
PurchaseCommon Shares 100,000 $8.09 $809,000.00
Disclosure

SEC source: 0001415889-25-006589 · form4-03042025_100358.xml · nonDerivative · entry 6

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 10,029,500

F7 · price: These shares were purchased in multiple transactions at prices ranging from $8.05 to $8.10.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 5,140,591 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 4,388,909 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI and TCP III.

Read SEC document
March 04, 2025 Filed Mar 4, 2025 22:03 UTC
TANG KEVINDirector
PurchaseCommon Shares 500,000 $7.92 $3,960,000.00
Disclosure

SEC source: 0001415889-25-006589 · form4-03042025_100358.xml · nonDerivative · entry 5

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 9,929,500

F6 · price: These shares were purchased in multiple transactions at prices ranging from $7.76 to $8.10.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 5,140,591 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 4,388,909 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI and TCP III.

Read SEC document
March 04, 2025 Filed Mar 4, 2025 22:03 UTC
TANG KEVINDirector
PurchaseCommon Shares 148,038 $8.00 $1,184,304.00
Disclosure

SEC source: 0001415889-25-006589 · form4-03042025_100358.xml · nonDerivative · entry 4

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 9,429,500

F5 · price: These shares were purchased in multiple transactions at prices ranging from $7.82 to $8.10.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 5,140,591 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 4,388,909 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI and TCP III.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 02:02 UTC
Greenleaf PeterDirector · Chief Executive Officer
SaleCommon Stock 164,947 $7.92 $1,306,380.24
Disclosure

SEC source: 0001600620-25-000024 · wk-form4_1741140121.xml · nonDerivative · entry 4

Greenleaf Peter · CIK 0001363683 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,788,945

F6 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs related to the March 2, 2022 and March 2, 2023 grants.

F7 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 01:58 UTC
Miller Joseph MChief Financial Officer
SaleCommon Stock 56,154 $7.92 $444,739.68
Disclosure

SEC source: 0001600620-25-000020 · wk-form4_1741139883.xml · nonDerivative · entry 4

Miller Joseph M · CIK 0001746372 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 577,361

F6 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs related to the March 2, 2022 and March 2, 2023 grants.

F7 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 01:57 UTC
Robertson Stephen P.EVP, General Counsel
SaleCommon Stock 57,607 $7.92 $456,247.44
Disclosure

SEC source: 0001600620-25-000019 · wk-form4_1741139835.xml · nonDerivative · entry 4

Robertson Stephen P. · CIK 0001837798 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 509,276

F6 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs related to the March 2, 2022 and March 2, 2023 grants.

F7 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 01:56 UTC
Donley Matthew MaxwellChief Operating Officer
SaleCommon Stock 58,991 $7.92 $467,208.72
Disclosure

SEC source: 0001600620-25-000018 · wk-form4_1741139793.xml · nonDerivative · entry 4

Donley Matthew Maxwell · CIK 0001636642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 680,465

F6 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs related to the March 2, 2022 and March 2, 2023 grants.

F7 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 22:03 UTC
TANG KEVINDirector
PurchaseCommon Shares 351,962 $8.02 $2,822,735.24
Disclosure

SEC source: 0001415889-25-006589 · form4-03042025_100358.xml · nonDerivative · entry 3

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 9,281,462

F4 · price: These shares were purchased in multiple transactions at prices ranging from $7.80 to $8.10.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 5,140,591 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 4,388,909 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI and TCP III.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 22:03 UTC
TANG KEVINDirector
PurchaseCommon Shares 100,720 $7.97 $802,738.40
Disclosure

SEC source: 0001415889-25-006589 · form4-03042025_100358.xml · nonDerivative · entry 2

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 8,929,500

F3 · price: These shares were purchased in multiple transactions at prices ranging from $7.80 to $8.05.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 5,140,591 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 4,388,909 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI and TCP III.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 01:59 UTC
Keenan GregChief Medical Officer
SaleCommon Stock 12,239 $8.00 $97,912.00
Disclosure

SEC source: 0001600620-25-000022 · wk-form4_1741139983.xml · nonDerivative · entry 2

Keenan Greg · CIK 0002044006 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,789

F2 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the January 30, 2024 grant.

F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 02:02 UTC
Greenleaf PeterDirector · Chief Executive Officer
SaleCommon Stock 195,593 $8.00 $1,564,744.00
Disclosure

SEC source: 0001600620-25-000024 · wk-form4_1741140121.xml · nonDerivative · entry 3

Greenleaf Peter · CIK 0001363683 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,953,892

F4 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) related to the February 20, 2024 grant and March 2, 2023 performance award.

F5 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 02:02 UTC
Greenleaf PeterDirector · Chief Executive Officer
GrantCommon Stock 333,705 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000024 · wk-form4_1741140121.xml · nonDerivative · entry 2

Greenleaf Peter · CIK 0001363683 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,149,485

F3 · shares: Represents grant of performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2024 and December 31, 2025.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 01:58 UTC
Miller Joseph MChief Financial Officer
SaleCommon Stock 61,859 $8.00 $494,872.00
Disclosure

SEC source: 0001600620-25-000020 · wk-form4_1741139883.xml · nonDerivative · entry 3

Miller Joseph M · CIK 0001746372 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 633,515

F4 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) related to the February 20, 2024 grant and March 2, 2023 performance award.

F5 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 01:58 UTC
Miller Joseph MChief Financial Officer
GrantCommon Stock 114,711 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000020 · wk-form4_1741139883.xml · nonDerivative · entry 2

Miller Joseph M · CIK 0001746372 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 695,374

F3 · shares: Represents grant of performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2024 and December 31, 2025.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 01:57 UTC
Robertson Stephen P.EVP, General Counsel
SaleCommon Stock 64,872 $8.00 $518,976.00
Disclosure

SEC source: 0001600620-25-000019 · wk-form4_1741139835.xml · nonDerivative · entry 3

Robertson Stephen P. · CIK 0001837798 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 566,883

F4 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) related to the February 20, 2024 grant and March 2, 2023 performance award.

F5 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 01:57 UTC
Robertson Stephen P.EVP, General Counsel
GrantCommon Stock 102,406 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000019 · wk-form4_1741139835.xml · nonDerivative · entry 2

Robertson Stephen P. · CIK 0001837798 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 631,755

F3 · shares: Represents grant of performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2024 and December 31, 2025.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 01:56 UTC
Donley Matthew MaxwellChief Operating Officer
SaleCommon Stock 65,902 $8.00 $527,216.00
Disclosure

SEC source: 0001600620-25-000018 · wk-form4_1741139793.xml · nonDerivative · entry 3

Donley Matthew Maxwell · CIK 0001636642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 739,456

F4 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) related to the February 20, 2024 grant and March 2, 2023 performance award.

F5 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 01:56 UTC
Donley Matthew MaxwellChief Operating Officer
GrantCommon Stock 135,567 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000018 · wk-form4_1741139793.xml · nonDerivative · entry 2

Donley Matthew Maxwell · CIK 0001636642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 805,358

F3 · shares: Represents grant of performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2024 and December 31, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 22:03 UTC
TANG KEVINDirector
PurchaseCommon Shares 399,280 $7.85 $3,134,348.00
Disclosure

SEC source: 0001415889-25-006589 · form4-03042025_100358.xml · nonDerivative · entry 1

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 8,828,780

F1 · price: The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $7.47 to $7.95. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1, and 3 through 7.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 5,140,591 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 4,388,909 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI and TCP III.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:59 UTC
Keenan GregChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 95,570 $0.00 Strike: $7.55 $0.00
Disclosure

SEC source: 0001600620-25-000022 · wk-form4_1741139983.xml · derivative · entry 3

Keenan Greg · CIK 0002044006 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,570

Underlying: Common Stock · 95,570 shares

Expires 2035-02-28

F4 · derivative.exercise_date: One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:59 UTC
Keenan GregChief Medical Officer
GrantCommon Stock 62,583 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000022 · wk-form4_1741139983.xml · nonDerivative · entry 1

Keenan Greg · CIK 0002044006 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,028

F1 · shares: Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 02:02 UTC
Greenleaf PeterDirector · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 443,973 $0.00 Strike: $7.55 $0.00
Disclosure

SEC source: 0001600620-25-000024 · wk-form4_1741140121.xml · derivative · entry 5

Greenleaf Peter · CIK 0001363683 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,973

Underlying: Common Stock · 443,973 shares

Expires 2035-02-28

F8 · derivative.exercise_date: One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 02:02 UTC
Greenleaf PeterDirector · Chief Executive Officer
GrantCommon Stock 290,728 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000024 · wk-form4_1741140121.xml · nonDerivative · entry 1

Greenleaf Peter · CIK 0001363683 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,815,780

F1 · shares: Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.

F2 · balance_after: Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 common shares were acquired on May 31, 2024 and 438 common shares were acquired on November 29, 2024.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:58 UTC
Miller Joseph MChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 124,393 $0.00 Strike: $7.55 $0.00
Disclosure

SEC source: 0001600620-25-000020 · wk-form4_1741139883.xml · derivative · entry 5

Miller Joseph M · CIK 0001746372 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,393

Underlying: Common Stock · 124,393 shares

Expires 2035-02-28

F8 · derivative.exercise_date: One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:58 UTC
Miller Joseph MChief Financial Officer
GrantCommon Stock 81,457 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000020 · wk-form4_1741139883.xml · nonDerivative · entry 1

Miller Joseph M · CIK 0001746372 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,663

F1 · shares: Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.

F2 · balance_after: Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,630 common shares were acquired on May 31, 2024 and 1,648 common shares were acquired on November 29, 2024.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:57 UTC
Robertson Stephen P.EVP, General Counsel
GrantEmployee Stock Option (right to buy) · Derivative 128,438 $0.00 Strike: $7.55 $0.00
Disclosure

SEC source: 0001600620-25-000019 · wk-form4_1741139835.xml · derivative · entry 5

Robertson Stephen P. · CIK 0001837798 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,438

Underlying: Common Stock · 128,438 shares

Expires 2035-02-28

F8 · derivative.exercise_date: One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:57 UTC
Robertson Stephen P.EVP, General Counsel
GrantCommon Stock 84,106 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000019 · wk-form4_1741139835.xml · nonDerivative · entry 1

Robertson Stephen P. · CIK 0001837798 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 529,349

F1 · shares: Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.

F2 · balance_after: Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 513 common shares were acquired on May 31, 2024 and 506 common shares were acquired on November 29, 2024.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:56 UTC
Donley Matthew MaxwellChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 126,416 $0.00 Strike: $7.55 $0.00
Disclosure

SEC source: 0001600620-25-000018 · wk-form4_1741139793.xml · derivative · entry 5

Donley Matthew Maxwell · CIK 0001636642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,416

Underlying: Common Stock · 126,416 shares

Expires 2035-02-28

F8 · derivative.exercise_date: One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:56 UTC
Donley Matthew MaxwellChief Operating Officer
GrantCommon Stock 82,781 $0.00 $0.00
Disclosure

SEC source: 0001600620-25-000018 · wk-form4_1741139793.xml · nonDerivative · entry 1

Donley Matthew Maxwell · CIK 0001636642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 669,791

F1 · shares: Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.

F2 · balance_after: Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 common shares were acquired on May 31, 2024 and 438 common shares were acquired on November 29, 2024.

Read SEC document
December 09, 2024 Filed Dec 9, 2024 21:52 UTC
TANG KEVINDirector
PurchaseCommon Shares 500,000 $9.09 $4,545,000.00
Disclosure

SEC source: 0001415889-24-028661 · form4-12092024_091246.xml · nonDerivative · entry 3

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 8,429,500

F4 · price: These shares were purchased in multiple transactions at prices ranging from $8.88 to $9.19.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 7,929,500 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCP III.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 21:52 UTC
TANG KEVINDirector
PurchaseCommon Shares 400,000 $9.01 $3,604,000.00
Disclosure

SEC source: 0001415889-24-028661 · form4-12092024_091246.xml · nonDerivative · entry 2

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 7,929,500

F3 · price: These shares were purchased in multiple transactions at prices ranging from $8.89 to $9.15.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 7,929,500 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCP III.

Read SEC document
December 05, 2024 Filed Dec 9, 2024 21:52 UTC
TANG KEVINDirector
PurchaseCommon Shares 300,000 $8.91 $2,673,000.00
Disclosure

SEC source: 0001415889-24-028661 · form4-12092024_091246.xml · nonDerivative · entry 1

TANG KEVIN · CIK 0001178579 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LP

Disclosed balance after: 7,529,500

F1 · price: The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $8.74 to $8.99. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1, 3 and 4.

F2 · ownership.nature: Tang Capital Partners, LP ("TCP") beneficially owns 7,929,500 shares and Tang Capital Partners III, Inc. ("TCP III") beneficially owns 500,000 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Kevin Tang is the sole director and Chief Executive Officer of TCP III, which is indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCP III.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:30 UTC GrantDirector Stock Option (right to buy) · Derivative 18,641 $0.00 Strike: $8.24 $0.00
Disclosure

SEC source: 0001600620-24-000120 · wk-form4_1732570246.xml · derivative · entry 2

Bailey Jeffrey Allen · CIK 0001500210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,641

Underlying: Common Shares · 18,641 shares

Expires 2034-11-21

F2 · derivative.exercise_date: The options shall vest one year from date of grant.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:30 UTC GrantCommon Shares 12,135 $0.00 $0.00
Disclosure

SEC source: 0001600620-24-000120 · wk-form4_1732570246.xml · nonDerivative · entry 1

Bailey Jeffrey Allen · CIK 0001500210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,491

F1 · shares: Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:33 UTC GrantDirector Stock Option (right to buy) · Derivative 31,688 $0.00 Strike: $8.24 $0.00
Disclosure

SEC source: 0001600620-24-000122 · wk-form4_1732570412.xml · derivative · entry 2

Johnson Craig A · CIK 0001370348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,688

Underlying: Common Shares · 31,688 shares

Expires 2034-11-21

F2 · derivative.exercise_date: The options shall vest one year from date of grant.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:33 UTC GrantCommon Shares 20,631 $0.00 $0.00
Disclosure

SEC source: 0001600620-24-000122 · wk-form4_1732570412.xml · nonDerivative · entry 1

Johnson Craig A · CIK 0001370348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,631

F1 · shares: Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:38 UTC GrantDirector Stock Option (right to buy) · Derivative 18,641 $0.00 Strike: $8.24 $0.00
Disclosure

SEC source: 0001600620-24-000126 · wk-form4_1732570731.xml · derivative · entry 2

Smith Karen L. · CIK 0001639637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,641

Underlying: Common Shares · 18,641 shares

Expires 2034-11-21

F2 · derivative.exercise_date: The options shall vest one year from date of grant.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:38 UTC GrantCommon Shares 12,135 $0.00 $0.00
Disclosure

SEC source: 0001600620-24-000126 · wk-form4_1732570731.xml · nonDerivative · entry 1

Smith Karen L. · CIK 0001639637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,807

F1 · shares: Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.